 |
|
Rheumatoid arthritis: past, present and future
Sang Cheol Bae
J Korean Med Assoc. 2010;53(10):842-842. DOI: https://doi.org/10.5124/jkma.2010.53.10.842
|
|
Citations to this article as recorded by
 Comparing Effectiveness Rituximab (Mabthera®) to Other Second-line Biologics for Rheumatoid Arthritis Treatment in Patients Refractory to or Intolerant of First-line Anti-tumor Necrosis Factor Agent: An Observational Study
Yong-Wook Park, Ki-Jo Kim, Hyung-In Yang, Bo Young Yoon, Sang Hyon Kim, Seong-Ho Kim, Jinseok Kim, Ji Seon Oh, Wan-Uk Kim, Yeon-Ah Lee, Jung-Yoon Choe, Min-Chan Park, Sang-Heon Lee
Journal of Rheumatic Diseases.2017; 24(4): 227. CrossRef
|